DXC Divests Healthcare Software Unit, Streamlines Business

DXC Technology DXC yesterday announced that it has agreed to sell its healthcare software provider business unit to privately-held Dedalus Group for a total cash consideration of $525 million. The transaction is anticipated to complete by March 2021.

DXC’s innovative healthcare software give clinicians and caregivers the tools they need to improve processes across the continuum of care. The company’s technology solutions provide tools to healthcare providers to better connect with their patients, which helps them boost productivity and patient outcomes.

The latest divestment can be seen as part of DXC’s strategy to offload non-core assets. Notably, the IT and consulting services provider announced last November that it is exploring options to divest three of its non-core businesses, including the State and Local HHS business, the horizontal BPS business and the workplace and mobility business. The three units account for about 25% of DXC’s total revenues, on a combined basis.

Read More

Has eGain (EGAN) Outpaced Other Computer and Technology Stocks This Year?

Investors focused on the Computer and Technology space have likely heard of eGain (EGAN), but is the stock performing well in comparison to the rest of its sector peers? A quick glance at the company’s year-to-date performance in comparison to the rest of the Computer and Technology sector should help us answer this question.

eGain is one of 611 companies in the Computer and Technology group. The Computer and Technology group currently sits at #7 within the Zacks Sector Rank. The Zacks Sector Rank gauges the strength of our 16 individual sector groups by measuring the average Zacks Rank of the individual stocks within the groups.

The Zacks Rank emphasizes earnings estimates and estimate revisions to find stocks with improving earnings outlooks. This system has a long record of success, and these stocks tend to be on track to beat the market over the next one to three months. EGAN

Read More

Join us June 17 for a live discussion on COVID-19 contact tracing and safe reopening strategies – TechCrunch

Contact tracing is a practice almost as old as epidemiology itself, but today’s technology means the way that we go about tracking the spread of a contagious illness within and between communities is changing very quickly. This presents an opportunity for learning more about the opportunities and challenges presented in extending contact tracing and exposure notification via digital means, especially as contact tracing is likely a key ingredient in any successful reopening of the economy in light of ongoing challenges posed by COVID-19.

To that end, we’re happy to be working with the COVID-19 Technology Task Force, as well as Harvard’s Berkman Klein Center, NYU’s Alliance for Public Interest Technology, Betaworks Studios and Hangar. We’ll be playing host on TC to their live-streamed discussion (embedded above) around contact-tracing and exposure-notification efforts, as well as how and when businesses can safely reopen, and what tools can help

Read More

Moderna Company estimates for increasing revenues

U.S. hits 4.5 million coronavirus cases, Vietnam posts record rise in  infections

Celebrations might be all together for Moderna NASDAQ: MRNA at https://www.webull.com/quote/nasdaq-mrna investors, with the examiners conveying a critical move up to their legal assessments for the organization. The investigators have forcefully expanded their income numbers, with a view that Moderna will make significantly a larger number of deals than they’d recently anticipated.

Following the update, the most recent agreement from Moderna’s twelve investigators is for incomes of US135m in 2020, which would mirror a sizeable 158% improvement in deals contrasted with the most recent year. The misfortune per share is relied upon to improve somewhat, diminishing to US1.39. However before this agreement update, the investigators had been anticipating incomes of US110m and misfortunes of US1.43 per share in 2020. We can see there’s certainly been an adjustment in assessment in this update, with the investigators controlling a sizeable move up to the current year’s income gauges, while simultaneously lessening their … Read More